Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179477 | SCV000231732 | benign | not specified | 2015-05-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000179477 | SCV000312113 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000179477 | SCV000519769 | benign | not specified | 2016-07-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001838557 | SCV002098527 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10 | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004706618 | SCV005228993 | benign | not provided | criteria provided, single submitter | not provided |